1. Home
  2. LMAT vs PRCT Comparison

LMAT vs PRCT Comparison

Compare LMAT & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • PRCT
  • Stock Information
  • Founded
  • LMAT 1983
  • PRCT 2009
  • Country
  • LMAT United States
  • PRCT United States
  • Employees
  • LMAT N/A
  • PRCT N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • PRCT Medical Specialities
  • Sector
  • LMAT Health Care
  • PRCT Health Care
  • Exchange
  • LMAT Nasdaq
  • PRCT Nasdaq
  • Market Cap
  • LMAT 2.0B
  • PRCT 2.1B
  • IPO Year
  • LMAT 2006
  • PRCT 2021
  • Fundamental
  • Price
  • LMAT $86.53
  • PRCT $34.63
  • Analyst Decision
  • LMAT Buy
  • PRCT Buy
  • Analyst Count
  • LMAT 6
  • PRCT 8
  • Target Price
  • LMAT $99.67
  • PRCT $70.00
  • AVG Volume (30 Days)
  • LMAT 184.3K
  • PRCT 1.0M
  • Earning Date
  • LMAT 10-30-2025
  • PRCT 10-27-2025
  • Dividend Yield
  • LMAT 0.92%
  • PRCT N/A
  • EPS Growth
  • LMAT 22.69
  • PRCT N/A
  • EPS
  • LMAT 2.05
  • PRCT N/A
  • Revenue
  • LMAT $234,639,000.00
  • PRCT $274,950,000.00
  • Revenue This Year
  • LMAT $16.32
  • PRCT $48.38
  • Revenue Next Year
  • LMAT $8.62
  • PRCT $30.87
  • P/E Ratio
  • LMAT $42.21
  • PRCT N/A
  • Revenue Growth
  • LMAT 14.11
  • PRCT 55.71
  • 52 Week Low
  • LMAT $71.42
  • PRCT $34.01
  • 52 Week High
  • LMAT $109.58
  • PRCT $103.81
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 40.07
  • PRCT 36.50
  • Support Level
  • LMAT $84.41
  • PRCT $34.01
  • Resistance Level
  • LMAT $89.48
  • PRCT $36.48
  • Average True Range (ATR)
  • LMAT 2.56
  • PRCT 1.58
  • MACD
  • LMAT -0.21
  • PRCT 0.00
  • Stochastic Oscillator
  • LMAT 28.64
  • PRCT 9.20

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: